Company

Sanofi’s Q2 Earnings Show 8.1% Global Sales Growth, Led by Dupixent and China Expansion

CompanyDrug

CSPC Pharmaceutical’s Albumin-Bound Docetaxel Receives Orphan Drug Designation for Gastric Cancer

Drug

Hybio Pharmaceutical’s Liraglutide Filing Accepted by NMPA, Becomes Domestic Leader in GLP-1 Analog

Drug

Roche’s Rozlytrek Wins NMPA Approval for NTRK Fusion Gene-Positive Tumors

CompanyDrug

Kira Pharmaceuticals’ KP104 Receives Orphan Drug Designation for PNH Treatment

Policy / RegulatoryR&D

Shenzhen Unveils Measures to Boost Biomedical and Medical Device Industries

Company

Merck’s Q2 Sales Surge 31% to USD 14.6B, Led by Keytruda and China Growth

CompanyDrug

Takeda’s Alunbrig Prescribed in China for ALK+ NSCLC Treatment

CompanyDeals

Cosmo Pharma’s Winlevi Cream Secures Greater China Licensing Deal with 3SBio

CompanyR&D

PerkinElmer and SCUT Launch Joint Translational Medicine Center

Policy / Regulatory

Sun Pharma’s Bicalutamide Supply Suspended in Multiple Chinese Regions

CompanyDrug

MabPharm’s CMAB015 Biosimilar Receives NMPA Approval for Clinical Study